Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger FYVE-type containing 27 (ZFYVE27, also known as Protrudin) is a peripheral membrane protein and a member of the FYVE protein family that binds phosphatidylinositol 3-phosphate and associates with the endosomal/endoplasmic reticulum membrane. ZFYVE27 contains several functional domains, including a Rab11-binding domain at the N-terminal region, a coiled-coil domain, and a FYVE finger domain at the C-terminal end, enabling it to interact with multiple partners involved in membrane trafficking and endoplasmic reticulum morphogenesis. The protein promotes neurite extension and axonal elongation in neurons by mediating vesicular transport and establishing neuronal polarity. Mutations in ZFYVE27 are associated with hereditary spastic paraplegia, highlighting its importance in neurodegenerative disease and suggesting potential as a therapeutic target. Oligomerization (dimer/tetramer forms) of ZFYVE27 is required for its function in neurite outgrowth, and functional disruption can cause pathological changes in neuronal morphology, including cytoplasmic swelling and altered ER structure.
Not applicable, as no interacting drugs are listed in current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger FYVE-type containing 27 (ZFYVE27).